Buyer Address and Facsimile Number Number of Common Shares Number of Series A Warrant Shares Number of Series B Warrant Shares Number of Series C Warrant Shares Purchase Price Legal Representative’s Address and Facsimile Number Cranshire Capital, L.P....Securities Purchase Agreement • January 13th, 2011 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
ContractWarrant to Purchase Common Stock • January 13th, 2011 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
FORM OF SERIES C WARRANT] PROVECTUS PHARMACEUTICALS, INC. Warrant To Purchase Common StockWarrant Agreement • January 13th, 2011 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
Provectus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [CRANSHIRE CAPITAL, L.P.], [OTHER BUYERS], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), [______________]1 (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanin
FORM OF SERIES B WARRANT] PROVECTUS PHARMACEUTICALS, INC. Warrant To Purchase Common StockWarrant to Purchase Common Stock • January 13th, 2011 • Provectus Pharmaceuticals Inc • Pharmaceutical preparations • New York
Provectus Pharmaceuticals, Inc., a Nevada corporation (the “Company”), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [CRANSHIRE CAPITAL, L.P.], [OTHER BUYERS], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon exercise of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), [______________]1 (subject to adjustment as provided herein) fully paid and non-assessable shares of Common Stock (as defined below) (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanin
